From tobacco to cyberwood(Apr. 2, 2015) - Humans have been inspired by nature since the beginning of time. We mimic nature to develop new technologies, with examples ranging from machinery to ...read more

New way to map important drug targets

Dec. 19, 2013 — Researchers have used new techniques and one of the brightest X-ray sources on the planet to map the 3-D structure of an important cellular gatekeeper in a more natural state than possible before.

The new approach, published December 20, 2013, in the journal Science, is a major advance in exploring G protein-coupled receptors (GPCRs) -- a vast, hard-to-study family of proteins that play a key role in human health. GPCRs are targeted by an estimated 40 percent of modern medicines.

"For the first time we have a room-temperature, high-resolution structure of one of the most difficult-to-study but medically important families of membraneproteins," said Vadim Cherezov, a structural biologist at The Scripps Research Institute (TSRI) who led the research. "And we have validated this new method so that it can be confidently used for solving new structures."

Significant Advantages

In the study, the scientists examined the human serotonin receptor, which plays a role in learning, mood and sleep and is the target of drugs that combat obesity, depression and migraines. The scientists prepared crystallized samples of the receptor in a fatty gel that mimics its environment in the cell.

Working at the Linac Coherent Light Source (LCLS) X-raylaser at the Department of Energy's (DOE's) SLAC National Accelerator Laboratory, the scientists then used a newly designed injection system, engineered by a team from Arizona State University, to stream the gel into the path of the X-ray pulses, which hit the crystals and produced patterns used to reconstruct a high-resolution, 3-D model of the receptor.

The method eliminates one of the biggest hurdles in the study of GPCRs. It is notoriously difficult to grow sufficiently large crystals of these proteins needed for conventional X-ray studies at synchrotrons. Because LCLS is a billion times brighter than synchrotrons and produces ultrafast snapshots, it enables researchers to use tiny crystals and collect data in the instant before any damage sets in.

"This is one of the niches that LCLS is perfect for," said SLAC Staff Scientist Sébastien Boutet, a co-author of the report. "With really challenging proteins like this you often need years to develop crystals that are large enough to study at synchrotron X-ray facilities."

Wei Liu, a TSRI staff scientist who was first author of the study, said, "It's a big advantage that you don't have to harvest individual crystals -- you can just load the whole gel-like sample with embedded microcrystals in the injector and start collecting data. It's also significant that the crystals don't have to be cryo-cooled in liquid nitrogen to protect them from radiation damage. Instead of looking at the samples at minus 173 degrees Celsius, we can look at them at room temperature -- much closer to the temperature of their naturalenvironment, which is body temperature."

While a team led by Scripps Research Institute scientists had previously determined the human serotoninstructure with conventional methods, that effort required the receptor to be frozen. It also took much longer.

Even after samples of a GPCR are crystallized and imaged, with conventional methods it can take several months to optimize the crystal size and collect enough synchrotron X-ray data to produce structural information, Cherezov noted. This new method can potentially condense that timeline to a matter of days.

'Just the Beginning'

Disorders linked to GPCRs include hypertension, asthma, schizophrenia and Parkinson's disease. Because of their vital role in regulating cells' signaling and response mechanisms and their importance to human health, advances in receptor-related research garnered the 2012 Nobel Prize in Chemistry.

So far, scientists have been able to map the structures of fewer than two dozen of the estimated 800 GPCRs in humans. The more accurate the structure, the better scientists can use it to create effective drug treatments without side effects.

"I view these recent experiments as just the beginning," Cherezov said. "Now it is time to start making a serious impact on the field of structural biology of G protein-coupled receptors and other challenging membraneproteins and complexes. The pace of structural studies in this field is breathtaking, and there is still a lot unknown."

The research was supported by the National Institutes of Health Common Fund in Structural Biology (grants P50 GM073197, P50 GM073210, R01 GM095583), the National Institute of General Medical Sciences (PSI:Biology grants U54 GM094618, U54 GM094599) and the National Science Foundation (award 1231306), with additional support from the Helmholz Association, the German Federal Ministry of Education and Research, and Science Foundation Ireland (07/IN.1/B1836, 12/IA/1255).

Feedback

Tell us what you think of Chemistry 2011 -- we welcome both positive and negative comments. Have any problems using the site? Questions?

Your Name:Your Email:Comments:Click button to submit feedback:

About us

Chemistry2011 is an informational resource for students, educators and the self-taught in the field of chemistry. We offer resources such as course materials, chemistry department listings, activities, events, projects and more along with current news releases.

The history of the domain extends back to 2008 when it was selected to be used as the host domain for the International Year of Chemistry 2011 as designated by UNESCO and as an initiative of IUPAC that celebrated the achievements of chemistry. You can learn more about IYC2011 by clicking here. With IYC 2011 now over, the domain is currently under redevelopment by The Equipment Leasing Company Ltd.

Events & Activities

Are you interested in listing an event or sharing an activity or idea? Perhaps you are coordinating an event and are in need of additional resources?
Within our site you will find a variety of activities and projects your peers have previously submitted or which have been freely shared through creative commons licenses.
Here are some highlights: Featured Idea 1, Featured Idea 2.

About you

Ready to get involved? The first step is to sign up by following the link: Join Here. Also don’t forget to fill out your profile including any professional designations.